X. Tong

发表

Propofol in subanesthetic doses terminates status epilepticus in a rodent model

M. Walker, M. Holtkamp, X. Tong, 2001, Annals of neurology.

The pharmacokinetics of vigabatrin in rat blood and cerebrospinal fluid

P. Patsalos, X. Tong, N. Ratnaraj, 2007, Seizure.

Comparison of Single‐ and Repeated‐Dose Pharmacokinetics of Diazepam

M. Walker, S. Shorvon, S. Shorvon, 1998, Epilepsia.

Comparison of serum, cerebrospinal fluid and brain extracellular fluid pharmacokinetics of lamotrigine

M. Alavijeh, P. Patsalos, X. Tong, 2000, British journal of pharmacology.

The pharmacokinetics and neuropharmacological action of the new antiepileptic drugs vigabatrin and levetiracetam

X. Tong, 2007 .

A microdialysis study of the novel antiepileptic drug levetiracetam: extracellular pharmacokinetics and effect on taurine in rat brain

P. Patsalos, X. Tong, 2001, British journal of pharmacology.

Vigabatrin extracellular pharmacokinetics and concurrent γ‐aminobutyric acid neurotransmitter effects in rat frontal cortex and hippocampus using microdialysis

P. Patsalos, X. Tong, N. Ratnaraj, 2009, Epilepsia.

Mitochondrial dysfunction associated with neuronal death following status epilepticus in rat

M. Walker, S. Heales, Hannah R Cock, 2002, Epilepsy Research.

Safety, tolerability, pharmacokinetics, and pharmacodynamics of single-dose antiinterleukin- 18 mAb GSK1070806 in healthy and obese subjects.

S. McHugh, I. Pouliquen, S. Dewall, 2014, International journal of clinical pharmacology and therapeutics.

Modulation of β-amyloid by a single dose of GSK933776 in patients with mild Alzheimer’s disease: a phase I study

H. Zetterberg, N. Andreasen, C. V. von Arnim, 2014, Alzheimer's Research & Therapy.